Has Kyle Amber, MD received payments from drug or device companies?

Yes. Drug and device makers reported $14,468 in general payments to Kyle Amber, MD across 15 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Kyle Amber, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Kyle Amber, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Kyle Amber, MD

Dermatology · Berwyn, ILNPI 1881012474

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $12,109 of the $14,468 with a category attached, or 83.7%. 7 manufacturers reported payments, led by Argenx US, Inc. at 50.2% of the total. Reporting peaked in 2022 at $9,112 and has fallen 59.2% since, to $3,715 in 2025.

$14,468in general payments, 2019–2025

Across 15 payments — averaging $964.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Argenx US, Inc.$7K
Biocryst Pharmaceuticals, Inc.$4K
Astrazeneca AB$2K
Astrazeneca UK Limited$778
Almirall LLC$413
Janssen Global Services, LLC$48
plus $30 from 1 others

$2,308,575in research payments, 2019–2025

Across 15 payments — averaging $153,905 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Astrazeneca UK Limited$2M
Sanofi$240K
Argenx US, Inc.$42K
Lilly USA, LLC$40K

What the payments were for

Consulting fees$12,10984%
Travel & lodging$2,11515%
Food & beverage$2442%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Argenx US, Inc.	6	$7,264
Biocryst Pharmaceuticals, Inc.	2	$3,685
Astrazeneca AB	2	$2,250
Astrazeneca UK Limited	2	$778
Almirall LLC	1	$413
Janssen Global Services, LLC	1	$48
Lilly USA, LLC	1	$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VYVGART$7,146
FASENRA$2,578

How this compares

$14,468 in reported general payments places this provider in the 85th percentile of 606 dermatology providers in Illinois.

See all dermatology providers in Illinois →

Medicare billing

Part B allowed, 2024

$79,555

Medicare patients

258

Services billed

1,216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OctagamImmun Globg(Igg)/Malt/Iga Ov50	46	$892,151
Dupixent PenDupilumab	196	$714,396
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50	45	$702,793
Humira(Cf) PenAdalimumab	45	$593,793
GammaplexImmun Glob G(Igg)/Gly/Iga 0-50	31	$521,316
OpzeluraRuxolitinib Phosphate	41	$81,179
ZoryveRoflumilast	15	$13,133
Doxycycline Hyclate	267	$9,084
Clobetasol Propionate	144	$7,819
Tacrolimus	37	$6,801
Mycophenolate Mofetil	95	$5,656
Epinephrine	15	$4,250
ValacyclovirValacyclovir Hcl	69	$2,895
Methylprednisolone	36	$2,650
Triamcinolone Acetonide	128	$2,014

Paid to pharmacies, not to this prescriber.

Other dermatology in Berwyn

Ahmad AminNaperville$4.1M
Raj ChovatiyaChicago$3.6M
George LewittNorthbrook$3M
Peter LioChicago$2.4M
Elizabeth KiracofeChicago$1.6M
Lana SchmidtEffingham$1.3M
Melissa AbramsVernon Hills$600K
Carolyn JacobChicago$566K
Walter LiszewskiChicago$414K
Emily RubensteinLincolnshire$359K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →